Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 06/30 10:04:19 pm
73.55 USD   +0.75%
06/30 IMPERIAL INNOVA : Says PsiOxus Signs Deal With Bristol-Myers Squibb
06/30 BRISTOL MYERS S : and PsiOxus Therapeutics Announce Immuno-Oncology ..
06/30 BRISTOL MYERS S : and PsiOxus Therapeutics Announce Immuno-Oncology ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Bristol Myers Squibb : Trademark Application for "ENFAPORT" Filed

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/30/2016 | 11:59pm CEST

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENFAPORT" by Nadine P. Flynn, representing Bristol-Myers Squibb. This application was made available to the public on June 17, 2016 (see also Trademarks).

The serial number for this application is 77545706.

The international trademark goods and services class code for this trademark application is 005. The applicant indicates that "Color is not claimed as a feature of the mark. The mark consists of the word 'ENFAPORT' within a single line border rectangle with a curved side, inside a shaded rectangle with a curved side, and a bow at the top of the curved sides in the rectangles."

As submitted by the applicant, this trademark application relates to the following goods and services: Pediatric feeding formula.

The owner/registrar information for this application is: Nadine P. Flynn, Bristol-Myers Squibb, Trademark Dept, 345 Park Ave, New York, NY 10154.

Keywords for this news article include: Trademarks, Bristol-Myers Squibb.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC

(c) 2016 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
06/30 BRISTOL MYERS SQUIBB : Trademark Application for "ENFAPORT" Filed
06/30 IMPERIAL INNOVATIONS : Says PsiOxus Signs Deal With Bristol-Myers Squibb
06/30 BRISTOL MYERS SQUIBB : and PsiOxus Therapeutics Announce Immuno-Oncology Clinica..
06/30 BRISTOL MYERS SQUIBB : and PsiOxus Therapeutics Announce Immuno-Oncology Clinica..
06/29 BRISTOL MYERS SQUIBB : MEDIA STATEMENT Bristol-Myers Squibb’s Response to ..
06/29 Intel Corporation Talking With Bankers About Selling Its Cyber Security Unit-..
06/29 BRISTOL-MYERS SQUIBB CO : ex-dividend day
06/27 BRISTOL MYERS SQUIBB : Sickle Cell Partnership Creates Demonstration Project to ..
06/27 BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Receives Breakthrough Therapy Designat..
06/27 BRISTOL MYERS SQUIBB : BMS in sickle cell partnership to help treat Angolan chil..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials